You were talking about linuron earlier, and that's a good example. Let's not forget that we were calling on the PMRA to authorize linuron and that we were in a race against time because, essentially, without approval from Canadian authorities, the manufacturer was saying, with good reason, that he could sell his products on the U.S. market. So it was one minute to midday and we didn't have the quantities we would have needed.
Furthermore, I would say that there is some form of protectionism. We chose to stop manufacturing this type of product in Canada. So we become terribly dependent on other countries.